AI-Driven Assessment of The Efficacy And Safety of Gene and Cell-Based Therapies for Ischemic Heart Disease: A Systematic Review of Clinical Trials. JOC. 2024;23(1):1065-1078. doi:10.66838/J.Carcinog.23.1.1065-1078